Ferdinand Groenewald

Ferdinand Groenewald is recorded as Chief Accounting Officer at Sadot Group Inc. (SDOT) since February 14, 2022, CFO at Sadot Group Inc. (SDOT), CFO at Streamex Corp. (STEX) since October 1, 2025 and Chief Accounting Officer at Streamex Corp. (STEX) since June 5, 2024. The newest filing on record that lists Ferdinand Groenewald as CFO at Sadot Group Inc. (SDOT) is dated August 23, 2021. Streamex Corp. reported in an 8-K filed March 20, 2026 that Ferdinand Groenewald resigned as Chief Financial Officer, effective March 15, 2026. Streamex Corp. reported in an 8-K filed November 19, 2025 that Ferdinand Groenewald was appointed Chief Financial Officer, effective October 1, 2025. Streamex Corp. reported in an 8-K filed June 10, 2024 that Ferdinand Groenewald was appointed interim chief financial officer, principal accounting officer and vice president of finance, effective June 5, 2024. Equibles holds 4 filed executive changes naming Ferdinand Groenewald; each is listed under recent activity with its source filing. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $162,304 for Ferdinand Groenewald in fiscal 2024. Disclosed compensation is on record for 2 fiscal years. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Sadot Group Inc. is classified in the Farm Products industry within the Consumer Defensive sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Dale Curtis Hogue, Jr. (CEO and Board Member), Heidi Hagen (CEO and Board Member), Holger Weis (CEO, Chairman and Board Member) and 7 others.